Raleigh Capital Management’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-102
Closed -$6.42K 653
2025
Q1
$6.42K Sell
102
-100
-50% -$6.18K ﹤0.01% 371
2024
Q4
$11.5K Hold
202
﹤0.01% 586
2024
Q3
$11.9K Buy
202
+29
+17% +$1.58K ﹤0.01% 557
2024
Q2
$9.34K Sell
173
-30
-15% -$1.65K ﹤0.01% 586
2024
Q1
$11.7K Buy
203
+105
+107% +$5.42K 0.01% 529
2023
Q4
$4.7K Buy
98
+65
+197% +$3.1K ﹤0.01% 747
2023
Q3
$1.69K Hold
33
﹤0.01% 787
2023
Q2
$1.9K Hold
33
﹤0.01% 735
2023
Q1
$2K Hold
33
﹤0.01% 768
2022
Q4
$1.95K Hold
33
﹤0.01% 689
2022
Q3
$2K Hold
33
﹤0.01% 638
2022
Q2
$2K Hold
33
﹤0.01% 528
2022
Q1
$2K Sell
33
-4
-11% -$204 ﹤0.01% 538
2021
Q4
$2K Buy
+37
New +$1.69K ﹤0.01% 268

Other funds holding CTVA

Raleigh Capital Management's CTVA Position: Q2 2025 in Review

Raleigh Capital Management sold out of Corteva (CTVA) in Q2 2025, closing a stake of 102 shares — an estimated $6.42K sold.

Raleigh Capital Management first reported a position in CTVA in Q4 2021 and held it in 14 quarters. The position peaked at $11.9K in Q3 2024. 1,400 funds tracked by Wall St. Rank hold CTVA as of Q2 2025.

  • Raleigh Capital Management reported no remaining Corteva position as of Q2 2025 after selling out during the quarter.
  • Raleigh Capital Management sold 102 Corteva shares in Q2 2025, an estimated $6.42K.
  • Raleigh Capital Management first reported a position in Corteva in Q4 2021 and held it in 14 quarters.
  • Raleigh Capital Management's Corteva position peaked at $11.9K in Q3 2024.
  • 1,400 funds tracked by Wall St. Rank held Corteva as of Q2 2025.

Based on Raleigh Capital Management's 13F filing for Q2 2025, filed 17 Jul 2025.